Role for immune monitoring to tailor induction prophylaxis in pediatric heart recipients.

about

Role for immune monitoring to tailor induction prophylaxis in pediatric heart recipients.

Item

http://www.wikidata.org/entity/Q38166794

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Role for immune monitoring to tailor induction prophylaxis in pediatric heart recipients.

@en

type

Item

label

Role for immune monitoring to tailor induction prophylaxis in pediatric heart recipients.

@en

prefLabel

Role for immune monitoring to tailor induction prophylaxis in pediatric heart recipients.

@en

P1476

Role for immune monitoring to tailor induction prophylaxis in pediatric heart recipients.

@en

P2093

Carl L Backer

http://www.w3.org/2001/XMLSchema#string

Elfriede Pahl

http://www.w3.org/2001/XMLSchema#string

Hardik Bhagat

http://www.w3.org/2001/XMLSchema#string

Jeffrey G Gossett

http://www.w3.org/2001/XMLSchema#string

John M Costello

http://www.w3.org/2001/XMLSchema#string

Kathleen L Matthews

http://www.w3.org/2001/XMLSchema#string

Philip T Thrush

http://www.w3.org/2001/XMLSchema#string

Reem Nubani

http://www.w3.org/2001/XMLSchema#string

P2860

Influence of induction therapy, immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation: data from the Spanish Post-Heart Transplant Tumour Registry.

Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients.

Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation.

Continuous infusion of thymoglobulin for induction therapy in pediatric heart transplant recipients; experience and outcomes with a novel strategy for administration.

Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients.

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.

Immunosuppression therapy for pediatric heart transplantation.

Posttransplantation lymphoproliferative disorder in kidney and heart transplant recipients receiving thymoglobulin: a systematic review.

Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation.

Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.

P304

79-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PETR.12193

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258957076

http://www.w3.org/2001/XMLSchema#string

P698

24283506

http://www.w3.org/2001/XMLSchema#string